18 August 2026, Israel: Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that its Chairman, Nir Nimrodi, will join the Company’s upcoming quarterly results conference call on August 18, 2026.
Mr. Nimrodi will address the current situation involving certain dissident shareholders. Mr. Nimrodi will discuss the Company’s perspective on these developments and the potential implications of those dissidents’ attempted actions for Evogene and its shareholders.
The conference call is scheduled for Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time).
To attend the conference, please register in advance: https://www.veidan-conferencing.com/evogene
The entire conference will be available online on the Company’s website a few days after the call.
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
